143 related articles for article (PubMed ID: 37918818)
1. The Effect of Udenafil on Heart Rate and Blood Pressure in Adolescents With the Fontan Circulation.
Edelson JB; Zak V; Goldberg D; Fleming G; Mackie AS; Patel JK; Files M; Downing T; Richmond M; Acheampong B; Cartoski M; Detterich J; McCrindle B; McHugh K; Hansen JE; Wagner J; Maria MD; Weingarten A; Nowlen T; Yoon JK; Kim GB; Williams R; Whitehill R; Kirkpatrick E; Yin S; Ermis P; Lubert AM; Stylianou M; Freemon D; Hu C; Garuba OD; Frommelt P; Goldstein BH; Paridon S; Garg R;
Am J Cardiol; 2024 Jan; 210():183-187. PubMed ID: 37918818
[TBL] [Abstract][Full Text] [Related]
2. Results of the FUEL Trial.
Goldberg DJ; Zak V; Goldstein BH; Schumacher KR; Rhodes J; Penny DJ; Petit CJ; Ginde S; Menon SC; Kim SH; Kim GB; Nowlen TT; DiMaria MV; Frischhertz BP; Wagner JB; McHugh KE; McCrindle BW; Shillingford AJ; Sabati AA; Yetman AT; John AS; Richmond ME; Files MD; Payne RM; Mackie AS; Davis CK; Shahanavaz S; Hill KD; Garg R; Jacobs JP; Hamstra MS; Woyciechowski S; Rathge KA; McBride MG; Frommelt PC; Russell MW; Urbina EM; Yeager JL; Pemberton VL; Stylianou MP; Pearson GD; Paridon SM;
Circulation; 2020 Feb; 141(8):641-651. PubMed ID: 31736357
[TBL] [Abstract][Full Text] [Related]
3. Design and rationale of the Fontan Udenafil Exercise Longitudinal (FUEL) trial.
Goldberg DJ; Zak V; Goldstein BH; McCrindle BW; Menon SC; Schumacher KR; Payne RM; Rhodes J; McHugh KE; Penny DJ; Trachtenberg F; Hamstra MS; Richmond ME; Frommelt PC; Files MD; Yeager JL; Pemberton VL; Stylianou MP; Pearson GD; Paridon SM;
Am Heart J; 2018 Jul; 201():1-8. PubMed ID: 29910047
[TBL] [Abstract][Full Text] [Related]
4. Impact of Udenafil on Echocardiographic Indices of Single Ventricle Size and Function in FUEL Study Participants.
Di Maria MV; Goldberg DJ; Zak V; Hu C; Lubert AM; Dragulescu A; Mackie AS; McCrary A; Weingarten A; Parthiban A; Goot B; Goldstein BH; Taylor C; Lindblade C; Petit CJ; Spurney C; Harrild DM; Urbina EM; Schuchardt E; Beom Kim G; Kyoung Yoon J; Colombo JN; Files MD; Schoessling M; Ermis P; Wong PC; Garg R; Swanson SK; Menon SC; Srivastava S; Thorsson T; Johnson TR; Krishnan US; Paridon SM; Frommelt PC;
Circ Cardiovasc Imaging; 2022 Nov; 15(11):e013676. PubMed ID: 36378780
[TBL] [Abstract][Full Text] [Related]
5. The Fontan Udenafil Exercise Longitudinal Trial: Subgroup Analysis.
Goldberg DJ; Hu C; Lubert AM; Rathod RH; Penny DJ; Petit CJ; Schumacher KR; Ginde S; Williams RV; Yoon JK; Kim GB; Nowlen TT; DiMaria MV; Frischhertz BP; Wagner JB; McHugh KE; McCrindle BW; Cartoski MJ; Detterich JA; Yetman AT; John AS; Richmond ME; Yung D; Payne RM; Mackie AS; Davis CK; Shahanavaz S; Hill KD; Almaguer M; Zak V; McBride MG; Goldstein BH; Pearson GD; Paridon SM;
Pediatr Cardiol; 2023 Dec; 44(8):1691-1701. PubMed ID: 37382636
[TBL] [Abstract][Full Text] [Related]
6. PDE 5 inhibition with udenafil improves left ventricular systolic/diastolic functions and exercise capacity in patients with chronic heart failure with reduced ejection fraction; A 12-week, randomized, double-blind, placebo-controlled trial.
Kim KH; Kim HK; Hwang IC; Cho HJ; Je N; Kwon OM; Choi SJ; Lee SP; Kim YJ; Sohn DW
Am Heart J; 2015 Jun; 169(6):813-822.e3. PubMed ID: 26027619
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of udenafil for the treatment of erectile dysfunction up to 12 hours after dosing: a randomized placebo-controlled trial.
Park HJ; Park JK; Park K; Min K; Park NC
J Sex Med; 2010 Jun; 7(6):2209-2216. PubMed ID: 20412426
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Udenafil for the Treatment of Pulmonary Arterial Hypertension: a Placebo-controlled, Double-blind, Phase IIb Clinical Trial.
Chang HJ; Song S; Chang SA; Kim HK; Jung HO; Choi JH; Lee JS; Kim KH; Jeong JO; Lee JH; Kim DK
Clin Ther; 2019 Aug; 41(8):1499-1507. PubMed ID: 31202506
[TBL] [Abstract][Full Text] [Related]
9. Results of a phase I/II multi-center investigation of udenafil in adolescents after fontan palliation.
Goldberg DJ; Zak V; Goldstein BH; Chen S; Hamstra MS; Radojewski EA; Maunsell E; Mital S; Menon SC; Schumacher KR; Payne RM; Stylianou M; Kaltman JR; deVries TM; Yeager JL; Paridon SM;
Am Heart J; 2017 Jun; 188():42-52. PubMed ID: 28577680
[TBL] [Abstract][Full Text] [Related]
10. The effect of udenafil on the hemodynamics of healthy male volunteers administered tamsulosin.
Kim MG; Kim JR; Kim BH; Lim KS; Shin SG; Jang IJ; Yu KS; Cho JY
Curr Med Res Opin; 2013 Jun; 29(6):685-93. PubMed ID: 23557068
[TBL] [Abstract][Full Text] [Related]
11. Impact of oral sildenafil on exercise performance in children and young adults after the fontan operation: a randomized, double-blind, placebo-controlled, crossover trial.
Goldberg DJ; French B; McBride MG; Marino BS; Mirarchi N; Hanna BD; Wernovsky G; Paridon SM; Rychik J
Circulation; 2011 Mar; 123(11):1185-93. PubMed ID: 21382896
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of once-daily dosing of udenafil in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.
Zhao C; Kim SW; Yang DY; Kim JJ; Park NC; Lee SW; Paick JS; Ahn TY; Min KS; Park K; Park JK
Eur Urol; 2011 Aug; 60(2):380-7. PubMed ID: 21458153
[TBL] [Abstract][Full Text] [Related]
13. Bosentan improves exercise capacity in adolescents and adults after Fontan operation: the TEMPO (Treatment With Endothelin Receptor Antagonist in Fontan Patients, a Randomized, Placebo-Controlled, Double-Blind Study Measuring Peak Oxygen Consumption) study.
Hebert A; Mikkelsen UR; Thilen U; Idorn L; Jensen AS; Nagy E; Hanseus K; Sørensen KE; Søndergaard L
Circulation; 2014 Dec; 130(23):2021-30. PubMed ID: 25446057
[TBL] [Abstract][Full Text] [Related]
14. Effect of Sildenafil on Pressure-Volume Loop Measures of Ventricular Function in Fontan Patients.
Butts RJ; Chowdhury SM; Baker GH; Bandisode V; Savage AJ; Atz AM
Pediatr Cardiol; 2016 Jan; 37(1):184-91. PubMed ID: 26409473
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
Germino FW
Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of udenafil, a new selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction.
Paick JS; Kim SW; Yang DY; Kim JJ; Lee SW; Ahn TY; Choi HK; Suh JK; Kim SC
J Sex Med; 2008 Apr; 5(4):946-953. PubMed ID: 18221288
[TBL] [Abstract][Full Text] [Related]
17. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
García-Morales LM; Berber A; Macias-Lara CC; Lucio-Ortiz C; Del-Rio-Navarro BE; Dorantes-Alvárez LM
Clin Ther; 2006 May; 28(5):770-82. PubMed ID: 16861099
[TBL] [Abstract][Full Text] [Related]
18. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
Luque Otero M; Martell Claros N;
Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
[TBL] [Abstract][Full Text] [Related]
19. Carvedilol Does Not Improve Exercise Performance in Fontan Patients: Results of a Crossover Trial.
Butts R; Atz AM; BaezHernandez N; Sutcliffe D; Reisch J; Mahony L
Pediatr Cardiol; 2021 Apr; 42(4):934-941. PubMed ID: 33585998
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the potential interaction between NaCl and prostaglandin inhibition in elderly individuals with isolated systolic hypertension.
Alam S; Purdie DM; Johnson AG
J Hypertens; 1999 Aug; 17(8):1195-202. PubMed ID: 10466476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
